Schannoma

Reading File
Finding Sources
Finding Sources
Searching PubMed

schwannoma diagnosis treatment

Reading File
Reading File
Reading File
Reading File
Loading Image
Loading Image
Excellent - I now have rich, comprehensive information from multiple authoritative textbooks. Here is the full clinical overview:

Schwannoma (Neurilemmoma)

Definition & Origin

A schwannoma is a generally benign, encapsulated tumor arising from Schwann cells of peripheral, cranial, or spinal nerve sheaths. Also called a neurilemmoma, it is the most common benign peripheral nerve sheath tumor. Unlike neurofibromas, schwannomas do not infiltrate adjacent nerve fascicles - they push the nerve fibers aside, which is the key to nerve-sparing surgery.
  • Harrison's Principles of Internal Medicine 22E, p. 765
  • Andrews' Diseases of the Skin, p. 719

Epidemiology & Associations

FeatureDetail
SexMore common in women (peripheral type)
Usual presentationSolitary, sporadic
NF2 (chromosome 22)Bilateral vestibular schwannomas; multiple schwannomas
NF1 (chromosome 17q11.2)Spinal nerve root schwannomas (less commonly)
Carney syndromeMelanotic psammomatous schwannoma + spotty pigmentation + myxomas + endocrine overactivity
Multiple schwannomas without NF features may be sporadic or familial (schwannomatosis).

Clinical Types & Locations

1. Vestibular Schwannoma (Acoustic Neuroma) - Most Common

  • Arises from the vestibular portion of CN VIII
  • Accounts for ~9% of all primary brain tumors
  • Symptoms: Progressive unilateral hearing loss, tinnitus, dizziness; with large tumors - brainstem/cerebellar compression
  • NF2 patients get bilateral vestibular schwannomas

2. Peripheral Schwannoma

  • Solitary nodule, 3-30 mm in diameter
  • Soft/firm, pale pink or yellowish
  • Common sites: flexor surfaces of arms/wrists/knees, scalp, neck, tongue
  • May or may not be painful; positive Tinel sign is characteristic

3. Plexiform Schwannoma

  • Involves multiple fascicles; occurs as solitary or multiple lesions
  • May be isolated or associated with NF1, NF2, or schwannomatosis

4. Ancient Schwannoma

  • Long-standing schwannoma with nuclear atypia - a benign degenerative change, NOT malignant
  • No mitotic figures; must be distinguished from malignant peripheral nerve sheath tumor (MPNST)

Imaging (MRI)

MRI is the investigation of choice:
  • Fusiform mass along the course of a major peripheral nerve
  • "Split fat sign" on T1: a rim of fat surrounding the lesion
  • "Target sign" on T2 (seen in ~50%): decreased central T2 signal with increased peripheral T2 signal - suggests benign diagnosis
  • Vestibular schwannoma: densely enhancing lesion, enlarges the internal auditory canal, extends into the cerebellopontine angle (CPA)
Postgadolinium MRI of right vestibular schwannoma (Harrison's, p. 765):
Postgadolinium MRI of a right vestibular schwannoma involving the internal auditory canal
Peripheral schwannoma of peroneal nerve with intraoperative view (Campbell's Orthopaedics 15e):
MRI and intraoperative photographs of schwannoma of the peroneal nerve
Red flags for malignancy on imaging:
  • Rapid size increase
  • Peripheral enhancement pattern
  • Perilesional soft-tissue edema
  • Cystic change within the tumor
  • Increased FDG uptake on PET scan

Histopathology - The Key Features

Schwannomas have two characteristic tissue patterns:
PatternDescriptionGross appearance
Antoni ACompact spindle cells with marked nuclear palisading; Verocay bodies (two rows of palisading nuclei separated by fibrillary material)Hard, firm
Antoni BLoose, myxomatous, degenerative; ectatic/thick-walled blood vessels; cystic spacesSoft, edematous
Immunohistochemistry:
  • S-100 positive (nuclear and cytoplasmic) - hallmark
  • Also positive for vimentin and myelin basic protein (in Antoni A)
  • EMA-positive capsule (derived from perineurium)
  • Very few/no nerve fibers within the tumor bulk (a compressed nerve may be seen at one edge)

Treatment

Peripheral schwannomas:
  • Surgical excision via longitudinal perineurial incision with careful blunt dissection
  • Tumor can be shelled out without sacrificing nerve fascicles
  • Excision is almost invariably curative
  • Transient neurologic deficits occur in ~1/3 of cases post-resection
  • Risk of neurologic injury is higher with tumors > 3 cm, age > 50, and longer symptom duration
Vestibular schwannomas:
  • Very small, asymptomatic lesions: observe with serial MRIs
  • Larger/symptomatic lesions: surgery or stereotactic radiosurgery (SRS)
  • In patients with small tumors and intact hearing: early surgical intervention improves chance of hearing preservation
Malignant variant (MPNST - "malignant schwannoma"):
  • Arises from long-standing neurofibromas in NF1 setting (NOT from benign schwannomas)
  • Treatment: wide resection + radiotherapy

Key Differentials

FeatureSchwannomaNeurofibroma
EncapsulationYesNo
Nerve involvementDisplaces fasciclesInfiltrates fascicles
NF associationNF2 (also NF1)NF1 (von Recklinghausen)
S-100PositivePositive (less uniform)
Malignant potentialVery rareHigher (plexiform type in NF1)
SurgeryNerve-sparing excision possibleMay require nerve sacrifice

Recent Evidence (2024-2026)

Two recent systematic reviews are worth noting for vestibular schwannoma management:
  • A 2024 network meta-analysis (PMID 39627752) compared treatment options for unilateral vestibular schwannoma across surgery, SRS, and observation.
  • A 2026 systematic review and meta-analysis (PMID 41794963) in Journal of Neurology evaluated quality of life across all three management strategies (observation, SRS, microsurgery), providing patient-centred guidance.

Sources: Harrison's Principles of Internal Medicine 22E (p. 765) | Andrews' Diseases of the Skin (p. 719) | Campbell's Operative Orthopaedics 15e (p. 1262-1263)
This is a shared conversation. Sign in to Orris to start your own chat.